Results 191 to 200 of about 1,293,738 (268)

Evaluating the effect of γ‐oryzanol on MASLD pathology using a medaka fish model

FEBS Open Bio, EarlyView.
This study explores a liver disease called MASLD, which is increasing worldwide and can lead to serious damage. Researchers used medaka fish instead of rodents to test a food compound, γ‐oryzanol. Fish fed this compound had less liver fat and healthier gut bacteria.
Yukako Ito, Haduki Asano, Ayano Ueki, Joe Sakamoto, Yasuhiro Kamei, Hayato Tokumoto, Ayaka Yazawa, Shigeki Kamitani   +7 more
wiley   +1 more source

A comparative analysis of health technology assessment decision-making for cancer drugs in Germany and England. [PDF]

Front Public Health
He J, Wei H, Mo Q, Liu Y, Li X, Yang Y, Tian L.   +6 more
europepmc   +1 more source

The Benefit Trajectory – a framework to support innovative and beneficial technology based solutions in integrated care

International Journal of Integrated Care, 2015
Ann-Catrine Monberg, Dorthe Furstrand Lauritsen, Lena Sundby Jensen, Lars Kayser   +3 more
doaj  

Strengthening health technology assessment (HTA) in the European Union: insights from Slovenia's implementation journey. [PDF]

Int J Technol Assess Health Care
Beravs-Bervar K, Goettsch W, Gutierrez-Ibarluzea I, Skali A, Rűther A, Lipska I, Turk E.   +6 more
europepmc   +1 more source

Reframing early health technology assessment through a lifecycle lens: Commentary on "defining early health technology assessment: building consensus using Delphi technique". [PDF]

Int J Technol Assess Health Care
Gilardino R, Mittmann N, Mueller D, Pichler F.   +3 more
europepmc   +1 more source

Integrating Equity in Topic Selection for Orphan Medicinal Products: Policy Implications for Health Technology Assessment in Rare Diseases. [PDF]

Appl Health Econ Health Policy
Hosseini F, Mobinizadeh M, Padula WV.
europepmc   +1 more source